4.6 Article

The impact of polyvascular disease on long-term outcome in percutaneous coronary intervention patients

期刊

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
卷 44, 期 3, 页码 231-239

出版社

WILEY
DOI: 10.1111/eci.12222

关键词

Coronary artery disease; percutaneous coronary intervention; polyvascular disease; prognosis

向作者/读者索取更多资源

BackgroundPrevious studies demonstrated the prognostic importance of concomitant polyvascular disease in patients with coronary artery disease (CAD). However, the significance of the number of diseased vascular territories and subclinical disease is unknown. Materials and methodsThe number of diseased vascular territories was evaluated in 2299 percutaneous coronary intervention (PCI) patients. Vascular disease was defined by documented atherosclerotic disease, either diagnosed in the medical history (clinical) or at the standardized cardiovascular screening (subclinical). The following territories were evaluated: cerebrovascular disease, peripheral arterial disease, abdominal aortic aneurysm and vascular renal disease. The outcome measures were all-cause mortality, cardiovascular mortality and a composite cardiovascular endpoint (myocardial infarction, stroke, cardiovascular mortality). Patients with monovascular disease (CAD) served as the reference category. Hazard ratios (HRs) were adjusted for baseline characteristics. ResultsMean follow-up was 73years. The HRs (95% confidence interval) for patients with two diseased territories compared to monovascular disease were for all-cause mortality 160 (114-225), cardiovascular mortality 213 (129-350) and the combined cardiovascular endpoint 166 (120-231). Moreover, the HRs (95% confidence intervals) for patients with more than two diseased territories compared to monovascular disease were for all-cause mortality 381 (245-592), cardiovascular mortality 440 (232-835) and the combined cardiovascular endpoint 275 (169-447). The HRs of patients with subclinical disease were comparable to the HRs of patients with clinical disease. ConclusionsIn patients undergoing PCI, the presence of subclinical and clinical polyvascular disease is associated with an increased long-term mortality and morbidity. Moreover, the outcome is highly influenced by the number of diseased territories.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据